Clinical Trial

Efficacy of Resveratrol Containing Mouthwash in Reducing Halitosis Related Porphyrymonas Gingivalis.

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated March 18, 2025 (before its estimated April 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of the study: To assess the efficacy of antioxidant (resveratrol) mouthwash in reducing the level of p. gingivitis and oral malodor over 7 day period among undergraduate dental student patients from Mustansiriyah University/College of Dentistry and Wasit University /College of Dentistry. Objectives: * To assess the efficacy of anti-oxidant and anti-inflammatory resveratrol mouthwash in reducing halitosis in undergraduate students with plaque-induced gingivitis patients. * To assess the efficacy of resveratrol mouthwash in reducing p. gingivalis in undergraduate students' patients with oral malodor. * To determine the relation between p.gingivalis and clinical periodontal parameters (plaque index, gingival index, bleeding on probing) among undergraduate students with plaque-induced gingivitis and halitosis.
Trial Details
NCT Number NCT06882564
Lead Sponsor Al-Mustansiriyah University
Conditions Halitosis, Mouth Disease, Plaque Induced Gingival Disease, Bleeding Gum, Peridontal Disease
Enrollment 54 participants
Start Date 2025-01-05
Primary Completion 2025-04-01 (estimated)
Study Completion 2025-11-01 (estimated)
Updated on ClinicalTrials.gov 2025-03-18